K
Keros Therapeutics (KROS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Keros Therapeutics (KROS)
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for patients suffering from hematological and musculoskeletal disorders with high unmet m... Read more
- USD57.32
- USD62.19
- USD57.32
- USD73.00
- -5.30%
- 0M
- 572.09k
- 306.27k
- 2.1B
- 27.02
- 33.70%
Stock News
3 hours ago
Former Boeing CEO and Seattle Mariners co-owner Frank Shrontz dies aged 92
Yahoo
4 hours ago
How previous investing mistakes are shaping my thinking on the latest stock gone wrong
CNBC
4 hours ago
Is Boeing Stock a Buy?
Yahoo
4 hours ago
Should You Buy ChargePoint While More Money Is Going Out Than Coming In?
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
